Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Abiraterone Acetate in Patients With Castration Resistant Prostate Cancer (CRPC) and Prior Therapy With Ketoconazole

NCT01199146 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT01199146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01199146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Abiraterone Acetate in Patients With Castration Resistant Prostate Cancer (CRPC) and Prior Therapy With Ketoconazole
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Completed
Start date
September 10, 2010
Completion date
March 14, 2016
Enrollment
42 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer